Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Angiology
Published in: International Journal of Angiology 1/1998

01-12-1998 | Original Articles

Effects of iloprost, either administered for 1 week or 4 weeks, on systemic hemodynamics, peripheral blood flow, and exercise tolerance in patients with peripheral occlusive arterial disease at leriche-fontaine stage III

Authors: Antonio Ceriello, M.D., Marco Sardina, M.D., D. Clin. Pharm, Enrico Motz, M.D., Sebastiano Lizzio, M.D., Duilio Tuniz, M.D., Carlo Bianchini, M.D.

Published in: International Journal of Angiology | Issue 1/1998

Login to get access
Metadata
Title
Effects of iloprost, either administered for 1 week or 4 weeks, on systemic hemodynamics, peripheral blood flow, and exercise tolerance in patients with peripheral occlusive arterial disease at leriche-fontaine stage III
Authors
Antonio Ceriello, M.D.
Marco Sardina, M.D., D. Clin. Pharm
Enrico Motz, M.D.
Sebastiano Lizzio, M.D.
Duilio Tuniz, M.D.
Carlo Bianchini, M.D.
Publication date
01-12-1998
Publisher
Springer-Verlag
Published in
International Journal of Angiology / Issue 1/1998
Print ISSN: 1061-1711
Electronic ISSN: 1615-5939
DOI
https://doi.org/10.1007/BF01616273

Other articles of this Issue 1/1998

International Journal of Angiology 1/1998 Go to the issue

Original Articles

Influence of aortic dissection on the clotting-fibrinolysis system and platelet function

Original Articles

Color-coded duplex sonography in the diagnosis of renal artery stenosis—A 3-year experience in a large community hospital

Original Articles

Results of the PHLEFI Study (PHLEbothrombosis-FIbrinolytic therapy): A prospective, multicenter study of the fate of 1498 patients receiving fibrinolytic therapy for deep vein thrombosis

Original Articles

Composite graft with coronary button reimplantation: Procedure of choice for aortic root replacement

Original Articles

Angiographic branching patterns of the splenic artery

Original Articles

Effects of the hypoxic test on left and right ventricular contractility in progressive systemic sclerosis with pulmonary arterial hypertension
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits